Latest Commercialization News

North Stawell Minerals Ltd (ASX, NSM) is advancing its gold exploration ambitions with a $3.6 million equity raising aimed at funding key projects near the prolific Stawell Gold Mine in Victoria. The capital injection will support drilling and geological modelling to unlock new gold discoveries under a thin sediment cover.

EVT Limited has officially kicked off the sale process for its prime Sydney CBD property at 525 George Street, offering a rare mixed-use development opportunity with significant growth potential.

Solstice Minerals’ initial RC drilling at Statesman Well reveals promising shallow high-grade gold intercepts, reinforcing the potential of its Yarri Project in WA’s Eastern Goldfields.

AusQuest has kicked off a significant drilling campaign at its Morrisey Magnetite Project in Western Australia, aiming to expand on promising iron ore discoveries and assess commercial viability.

Olympus Corporation has launched a nationwide emphysema screening campaign in the US powered by 4DMedical’s AI lung density analysis, marking a major commercial milestone for the Australian medtech firm.

IperionX has secured its first U.S. Army task order worth $1.3 million under a $99 million SBIR Phase III contract, marking a significant step in reshoring titanium production for U.S. defense needs.

Articore Group reaffirms its FY25 financial guidance while initiating a strategic review to unlock shareholder value, coinciding with the appointment of Vivek Kumar as Group CEO.

Cyclopharm Limited has secured the maximum five-year U.S. patent extension for its flagship Technegas® Kit, extending market exclusivity to 2031 and reinforcing its strategic foothold in pulmonary imaging.

Finbar Group has fast-tracked Ronald Chan’s appointment as CEO, aiming to leverage his deep company experience to strengthen its development pipeline and growth strategy.

Finder Energy has spotlighted its Kuda Tasi and Jahal oil development opportunity at the APAC Energy Capital Assembly, revealing a robust resource base and a streamlined development strategy promising rapid returns.

Zenith Minerals has secured exclusive subsurface exploration and mining rights over a key tenement package adjacent to its Dulcie Far North gold resource, significantly expanding its footprint in Western Australia's Marvel Loch–Forrestania gold belt. The deal includes milestone-based options for full ownership and a royalty agreement, setting the stage for accelerated resource growth.

Chimeric Therapeutics has secured a $2.5 million advance against its FY25 R&D tax incentive, bolstering funding for its clinical trial pipeline and operational needs. This move complements recent capital raises and underscores the company’s strategic financial management amid its oncology-focused cell therapy development.